Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 11.65
+0.13 (1.13%)
At close: Sep 5, 2025
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 25.98 billion as of September 5, 2025. Its market cap has decreased by -0.38% in one year.
Market Cap
25.98B
Enterprise Value
26.60B
Revenue
4.91B
Ranking
n/a
PE Ratio
23.89
Stock Price
11.65
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 25.98B, an increase of 16.30%. That is a compound annual growth rate of 5.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 25.98B | -1.64% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 482.35B |
| WuXi AppTec | 313.22B |
| Shenzhen Mindray Bio-Medical Electronics | 287.79B |
| Sichuan Biokin Pharmaceutical | 155.60B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.00B |
| Aier Eye Hospital Group | 120.10B |
| Shanghai United Imaging Healthcare | 116.97B |
| Yunnan Baiyao Group Co.,Ltd | 105.81B |